GLP-1 & PCOS: Why So Many Women Were Misdiagnosed
From A GLP-1 Guide to Metabolic Health: The Plus SideZ Podcast · · 1 hr 31 min
This plays from the publisher's own server. We do not host a copy.
Description
Linktree for Community Resources (https://linktr.ee/theplussidez)
Need help appealing GLP-1 insurance denials? findhonestcare.com/kim (https://www.findhonestcare.com/?utm_source=podcast&utm_medium=audio&utm_campaign=kim)
Ro - Telehealth for GLP1 Weight Management Ro.Co/PlusSideZ (https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55) _________________________________________________________________________
What if millions of women with PCOS were misunderstood for years because the condition was treated mainly as a reproductive disorder instead of a metabolic disease tied to insulin resistance, obesity, hormones, and fertility?
In this episode of The Plus SideZ Podcast, Dr. Melanie Cree, a pediatric endocrinologist, obesity researcher, and PCOS/PMOS expert, explains the recent global consensus to rename PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect the condition’s metabolic and hormonal impact.
Dr. Cree breaks down how delayed diagnosis and outdated understanding may have prevented many patients from getting earlier metabolic treatment and intervention.
We discuss: Why so many women with PCOS were misunderstood or dismissed The connection between PCOS, PMOS, insulin resistance, obesity, and fertility
- Why weight gain is not just about willpower
- Adolescent PCOS and why early intervention matters
- GLP-1 medications like semaglutide for PCOS/PMOS
- Emerging research focused on ovulation, fertility, and metabolic health
- How hormones, appetite, and metabolism are connected
- Why the PMOS name change could improve diagnosis and treatment
Dr. Cree also shares information about her ongoing research and studies exploring how GLP-1 medications may help improve metabolic and reproductive health in people with PCOS/PMOS.
Learn more about studies https://medschool.cuanschutz.edu/pediatrics/sections/endocrinology/endocrinology-research/cree-lab/Cree-Melanie-UCD4665?utm_source=chatgpt.com
_________________________________________________________________________
Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join
_________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy
Send us Fan Mail! (https://www.buzzsprout.com/2167931/fan_mail/new)
Support the show (https://www.buzzsprout.com/2167931/support)
Kim Carlos, Executive Producer
TikTok (https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc)
Instagram (https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr)
Kat Carter, Producer
TikTok (https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc)
Instagram (https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==)
Back to A GLP-1 Guide to Metabolic Health: The Plus SideZ Podcast · Report a problem